References
- Matheson A. Ghostwriting: the importance of definition and its place in contemporary drug marketing. BMJ 2016;354: published online 30 August 2016, doi:10.1136/bmj.i4578
- ICMJE. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals: Updated December 2017. Available at: http://www.icmje.org/icmje-recommendations.pdf [Last accessed 28 January 2018]
- Battisti WP, Wager E, Baltzer L, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med 2015;163:461-4
- Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005;21:317-21
- Hamilton CW, Royer MG. AMWA position statement on the contributions of medical writers to scientific publications. AMWA J 2003;18:13-16
- International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Japanese Pharmaceutical Manufacturers Association (JPMA). Pharmaceutical Research and Manufacture. Joint position on the publication of clinical trial results in the scientific literature. 2010. Available at: http://www.efpia.eu/uploads/Modules/Documents/20100610_joint_position_publication_10jun2010.pdf [Last accessed 12 December 2017]
- Committee On Publication Ethics (COPE). Code of conduct and best practice guidelines for journal editors. 2011. Available at: http://publicationethics.org/files/Code%20of%20Conduct_2.pdf [Last accessed 12 December 2017]
- World Association of Medical Editors (WAME). Recommendations on publication ethics policies for medical journals. 2016. Available at: http://www.wame.org/about/recommendations-on-publication-ethics-policie [Last accessed 12 December 2017]
- Marusic A, Bosnjak L, Jeroncic A. A systematic review of research on the meaning, ethics and practices of authorship across scholarly disciplines. PloS One 2011;6:e23477
- AMWA–EMWA–ISMPP. Joint position statement on the role of professional medical writers. Released January 2017. Available at: http://www.ismpp.org/assets/docs/Inititives/amwa-emwa-ismpp%20joint%20position%20statement%20on%20the%20role%20of%20professional%20medical%20writers_january%202017.pdf [Last accessed 12 December 2017]
- DeTora LM. The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship. Int J Clin Pract 2016;70:630-3
- International Society for Medical Publication Professionals Issues and Actions Committee. “Ghostwriting” and the professional medical writer. 2011. Available at: http://www.ismpp.org/assets/docs/Inititives/advocacy/ismpp_ghost_writing_vs_professional_medical_writing_oct_2011.pdf [Last accessed 12 December 2017]
- Jacobs A, Carpenter J, Donnelly J, et al. The involvement of professional medical writers in medical publications: results of a Delphi study. Curr Med Res Opin 2005;21:311-16
- Wislar JS, Flanagin A, Fontanarosa PB, DeAngelis CD. Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ 2011;343: published online 25 October 2011, doi:10.1136/bmj.d6128
- World Medical Association. Declaration of Helsinki: ethical principals for medical research involving human subjects. Updated October 2013. Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ [Last accessed 12 December 2017]
- Matheson A. The ICMJE recommendations and pharmaceutical marketing – strengths, weaknesses and the unsolved problem of attribution in publication ethics. Medical Ethics 2016;17:20
- Matheson A. How industry uses the ICMJE guidelines to manipulate authorship – and how they should be revised. PLoS Med 2011;8:e1001072
- Wager E, Woolley K, Adshead V, et al. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the global publication survey. BMJ Open 2014;14:e004780
- Jackson S, Billiones R. A career guide to medical writing: ever thought about being a medical writer? 2016. Available at: https://www.emwa.org/Documents/Resources/EMWA%20MW%20Career%20Guide%20Oct2016.pdf [Last accessed 24 February 2018]
- Jacobs A. Adherence to the CONSORT guideline in papers written by professional medical writers. Medical Writing 2010;19:196-200
- Woolley KL, Lew RA, Stretton S, et al. Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: a systematic, controlled, retrospective study. Curr Med Res Opin 2011;27:1175-82
- Gattrell WT, Hopewell S, Young K, et al. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study. BMJ Open 2016;6:e010329
- A. Flanagin Authorship: definition, criteria, contributions, and requirements. In: AMA Manual of Style: A Guide for Authors and Editors. Iverson C, Christiansen S, Flanagin A, et al. (Eds). New York: Oxford Univ Press, 2007:128-31
- Leventhal PS. Can a medical writer submit a manuscript on behalf of an author? Medical Writing 2017;26:45-6
- Rennie D, Yank V, Emanuel L. When authorship fails. A proposal to make contributors accountable. JAMA 1997;278:579-85
- Marusic A, Hren D, Mansi B, et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Medicine 2014;12:197
- Matheson A. Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature. Medical Writing 2016;25:25-30
- Clement TP. Authorship matrix: a rational approach to quantify individual contributions and responsibilities in multi-author scientific articles. Sci Eng Ethics 2014;20:345-61